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A retrospective cross-sectional study: fresh cycle
endometrial thickness is a sensitive predictor of
inadequate endometrial thickness in frozen
embryo transfer cycles
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Abstract
Background: The purpose of this study is to assess predictors of inadequate endometrial cavity thickness (ECT),
defined as < 8 mm, in frozen embryo transfer (FET) cycles.
Methods: This is a retrospective cross-sectional study at an academic fertility center including 274 women who
underwent their first endometrial preparation with estradiol for autologous FET in our center from 2001-2009.
Multivariable logistic regression was performed to determine predictors of inadequate endometrial development in
FET cycles.
Results: Neither age nor duration of estrogen supplementation were associated with FET endometrial thickness.
Lower body mass index, nulliparity, previous operative hysteroscopy and thinner fresh cycle endometrial lining
were associated with inadequate endometrial thickness in FET cycles. A maximum thickness of 11.5 mm in a fresh
cycle was 80% sensitive and 70% specific for inadequate frozen cycle thickness.
Conclusions: Previous fresh cycle endometrial cavity thickness is associated with subsequent FET cycle endometrial
cavity thickness. Women with a fresh cycle thickness of 11.5 mm or less may require additional intervention to
achieve adequate endometrial thickness in preparation for a frozen cycle.
Keywords: Endometrial thickness, Frozen embryo transfer, Estrogen supplementation
Background
As in vitro fertilization (IVF) culture techniques con-
tinue to improve, the number of embryos transferred in
each cycle decreases. Transferring fewer embryos is a
key component in preventing multiple gestations and
their associated complications. As a result, fresh IVF cy-
cles often lead to supernumerary embryos. Cryopreser-
vation of embryos created during fresh IVF cycles
provides a less expensive and time-intensive opportunity
for pregnancy. In addition, vitrification has proven to be
a superior method for cryopreservation, further improv-
ing frozen embryo transfer (FET) pregnancy rates [1,2].
Therefore, optimization of the FET cycle is crucial.
For FET, the endometrium is frequently artificially pre-
pared with estrogen and progesterone supplementation
in order the match the endometrial stage during the crit-
ical implantation window [3]. There are a number of
protocols used in endometrial preparation [4]. The opti-
mal endometrial thickness is unclear. However, several
studies suggest a thickness < 8 mm is associated with
implantation failure in both fresh and frozen embryo
transfer cycles [5-8]. Given the resources involved in IVF
and FET cycles, optimization of an individual’s treatment
plan is critical. Women preparing for FET will often re-
quire additional estrogen supplementation, or other
intervention, if their endometrium is thin. The objective
of this study is to determine predictors that may identify
women who require additional estrogen supplementa-
tion to attain adequate endometrial thickness in
* Correspondence: patricia.jimenez@utsouthwestern.edu
1Department of Obstetrics and Gynecology, University of Texas Southwestern
Medical Center, Dallas, TX, USA
Full list of author information is available at the end of the article
© 2013 Jimenez et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Jimenez et al. Reproductive Biology and Endocrinology 2013, 11:35
http://www.rbej.com/content/11/1/35
preparation for FET cycles to inform future FET cycle
planning.
Methods
This was a retrospective cross-sectional study. STROBE
guidelines for cross-sectional studies were followed [9].
Patients who underwent fresh autologous oocyte retrieval
with embryo transfer cycle and a subsequent medicated
FET cycle within our center between January 2001 and
February 2009 were eligible. Only the first FET cycle in
which oral estradiol was used for endometrial preparation
was included. Embryos were cryopreserved using a slow
freeze protocol. All frozen embryo transfers were
performed at the blastocyst stage. Donor oocyte recipients
and gestational carriers were excluded. The Institutional
Review Board at Washington University School of
Medicine approved this study.
Per protocol in our center for blastocyst stage trans-
fers, patients begin oral estradiol 2 mg three times a day
on cycle day 1. After at least 12 days of oral estradiol, a
serum progesterone and ultrasound is performed to
measure endometrial cavity thickness (ECT). If proges-
terone is < 2.5 ng/ml and endometrial thickness is at
least 8 mm, patients begin IM progesterone two days
later and embryo transfer is performed after five days of
progesterone. If endometrial thickness is < 8 mm, estra-
diol replacement is continued based on physician prefer-
ence as oral estradiol 2 mg three times a day or the
addition of transdermal estrogen (0.1 mg patches) with
re-evaluation after one week.
Medical charts of subjects were reviewed and the fol-
lowing data were collected: age, ethnicity, infertility diag-
nosis, gravity, parity, body mass index (BMI), dosage and
duration of estradiol supplementation, prior uterine sur-
gery, endometrial thickness in the fresh and FET cycle,
number of embryos transferred, and pregnancy outcome
of the fresh and FET cycle.
Three hundred and six subjects met inclusion criteria.
There was incomplete data available on 15 patients and
17 patients had cryopreserved embryos from two fresh
cycles transferred during the FET cycle. The remaining
274 subjects were included in the analysis. Standard uni-
variate analyses were performed to determine associa-
tions between inadequate endometrial development
(defined as < 8 mm) and the following variables: age,
duration of estrogen supplementation, BMI, history of
prior pregnancy, history of prior operative hysteroscopy
and endometrial thickness in fresh embryo transfer
cycle. Variables with a p-value <0.05 in the univariate
analyses were entered into a logistic regression model
assessing their association with inadequate endometrial
development. All analyses were performed in the Statis-
tical Package for the Social Science (SPSS) version 16.0
(SPSS Inc., Chicago, IL).
Results
The mean ECT for all FET cycles was 9.2 ± 2.7 mm. Nei-
ther age nor duration of estrogen supplementation was
associated with adequate or inadequate endometrial de-
velopment (Table 1). Subjects with inadequate endomet-
rial development during FET had a lower BMI (22.7±3.51
vs. 25.62±5.54 kg/m2; p <0.0001), they were less likely to
have a prior pregnancy (70.6% vs. 87.4%; p=0.001), they
were more likely to have a history of uterine surgery (7.4%
vs. 1.9%; p=0.04) and a thinner endometrial lining during
a fresh cycle (10.05±1.89 vs. 12.93±3.12 mm; p<0.001).
The majority of patients (67%) with an inadequate endo-
metrial thickness on initial evaluation ultimately had ap-
propriate endometrial development after further estradiol
supplementation (Figure 1).
Multivariate analysis was performed to control for the
effect of each of the significant characteristics. Similar re-
lationships were found. Lower BMI had a 0.87 odds ratio
(OR) of inadequate thickness. Each unit decrease of BMI
resulted in an approximate 13% decrease in odds of an ad-
equate endometrium. Prior pregnancy had an OR of 0.4
and operative hysteroscopy had an almost 7-fold increase
risk of inadequate thickness. Endometrial thickness in the
previous fresh cycle had a 0.58 OR (Table 2).
Because endometrial thickness is potentially modifiable
in an FET cycle with variations in estradiol administration,
we wanted to determine if a minimum endometrial thick-
ness in fresh IVF cycles would help determine what the
endometrial thickness would be after artificial preparation.
To do this, we then created an ROC curve that showed
that fresh cycle maximum endometrial thickness of 11.5
mm is 80% sensitive and 70% specific for predicting inad-
equate endometrial thickness in a FET cycle (Figure 2).
Discussion
Our data indicate that lower BMI, nulligravidity, previ-
ous uterine surgery, and a thinner endometrial lining
during a fresh cycle are associated with inadequate
Table 1 Univariate analysis of variables associated with






Age (years) 33.44±4.16 33.93±3.85 0.4










Fresh cycle ECT (mm) 10.05±1.89 12.93±3.12 <0.001
a – endometrial cavity thickness; b – body mass index; (χ2 for dichotomous
variables, Student’s t-test for continuous variables)
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endometrial thickness. In addition, a fresh cycle max-
imum endometrial thickness of 11.5 mm was found to
be a predictor of inadequate endometrial development
in a FET cycle indicating that additional estrogen supple-
mentation may be necessary for these cycles. Although
the difference we found in fresh cycle endometrial thick-
ness of 10 mm versus 12.9 mm may not represent a clin-
ically significant difference in implantation rate or
pregnancy outcome, it may indicate impaired endomet-
rial development.
Bromer et al. also found a positive correlation between
endometrial thickness and BMI in patients undergoing
clomiphene citrate or FSH treatment [10]. We did not
find a significant difference in adequate endometrial de-
velopment based on age or fertility diagnosis as this
group. However, it is possible these patients in our study
required additional estrogen during the FET preparation
to attain adequate endometrial thickness, and therefore,
masking the difference.
When endometrial development is inadequate, it is
reasonable to continue estrogen supplementation at the
same dose. A potential alternative to unresponsive endo-
metrium is a trial of estradiol via a different route of ad-
ministration. Because transdermal estradiol does not
undergo liver metabolism, there is lower conversion to
estrone, and possibly a varied effect on the endometrium
[11]. With both interventions, most patients in our study
ultimately demonstrated adequate endometrial develop-
ment and thickness (Figure 1).
Endometrial thickness has long been used as a marker
of adequate receptivity of the uterus and as a prognostic
factor in embryo transfers. Several studies suggest that
pregnancy is less likely when the endometrium is < 8
mm [5-8]. Endometrial thickness < 8 mm does not ex-
clude the possibility of pregnancy, but it is less optimal.
In the search for additional markers of success, recent
studies have focused on endometrial patterns and sub-
endometrial blood flow as a useful adjunct in predicting
successful IVF outcomes. A study by Singh et al.,
looking at endometrial thickness, pattern and sub-
endometrial blood flow found a higher pregnancy rate
when blood flow to the endometrium was in Zone III
(Inner hypoechogenic zone of vascular penetration).
They also found that pregnancy rates were highest with
Figure 1 Flow chart of the management of patients with inadequate endometrial cavity thickness (ECT) on first evaluation.
Table 2 Multivariate analysis of factors predictive of
inadequate endometrial thickness in FET cycles
ORa 95% CIb
Lower Upper
BMIc 0.867 0.794 0.947
History of previous pregnancy 0.405 0.179 0.913
History of operative hysteroscopy 6.96 1.476 32.824
Fresh cycle ECTd 0.583 0.489 0.695
a – odds ratio; b – confidence interval; c – body mass index; d – endometrial
cavity thickness
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an endometrial thickness between 8-10 mm [12]. Chen et
al., recently evaluated the combined analysis of endometrial
thickness and pattern in predicting outcome of IVF. The
author noted that a no triple line endometrial pattern even
with a moderate endometrial thickness of 7-14 mm had a
detrimental effect on pregnancy outcome, although not the
occurrence of pregnancy [13]. They concluded that when a
thinner endometrium (< 8 mm) and no triple-line endo-
metrial pattern coexist in an IVF candidate, cryopreserva-
tion should be recommended. Despite these findings
supporting the importance of endometrial thickness and
development, it is important to note that these are surro-
gate markers of IVF success. Endometrial thickness, in
addition to other factors, should be considered.
Several endometrial preparation protocols are utilized,
as well as multiple other compounds to attain proper
endometrial development. Low-dose aspirin supplemen-
tation in women with impaired uterine perfusion may
improve uterine blood flow and lead to pregnancy rates
similar to women with normal uterine perfusion [14].
Women with uterine fibrosis or thin endometrium for un-
known reasons may benefit from prolonged treatment
with pentoxifylline and tocopherol [15,16]. Takasaki et al.
showed improvement in endometrial thickness and uter-
ine radial artery resistance after treatment with either vita-
min E, I-arginine or sildenafil citrate [17]. Granulocyte
colony-stimulating factor (G-CSF) was also recently
shown to increase endometrial thickness [18].
FET is an effective, efficient and affordable means of
attaining pregnancy for the patient undergoing IVF.
Cryopreservation allows for a decrease in the number of
embryos transferred in IVF cycles, while the ability to
use preserved embryos in the future leads to an increase
in cumulative pregnancy rates. In the patient undergoing
FET, predictors of inadequate endometrial development,
and potentially inadequate thickness, may help the clin-
ician to be aware and prepared prior to initiation of a
new cycle.
Endometrial thickness remains an easily measured and
long-employed method of predicting endometrial readi-
ness. In FET cycles in our center, we found that one
factor influencing endometrial development is previous
endometrial thickness < 11.5 mm. This provides import-
ant information for the clinician as these patients may
require additional estrogen supplementation. Prepar-
ation of the endometrium for FET is the only easily
modifiable factor to improve ECT. Other potential fac-
tors we identified that can be modified are lower BMI
and uterine surgery. Good surgical technique to prevent
synechia is critical for adequate endometrial develop-
ment and should always be practiced. However, in
women who have already undergone surgery, this is no
longer modifiable. Our data suggests that lower, al-
though normal, BMI is associated with a thinner endo-
metrium. Recommending weight gain would not be
appropriate to improve endometrial thickness, and
therefore, BMI is not easily modifiable. Our study assists
in cycle planning and preparation, and therefore, may
decrease prolonged cycles or cancellation and limit costs
related to extra visits, ultrasounds and monitoring.
In addition, future study of the employment of ultra-
sound evaluation of blood flow and pattern would be
helpful to determine its utility in making decisions re-
garding embryo transfer. More research is needed to
Figure 2 Receiver operator characteristic (ROC) curve for the predictive value of fresh endometrial thickness for FET
endometrial thickness.
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better understand the mechanism of decreased endo-
metrial thickness as well as how to optimize pregnancy
in these patients.
Conclusions
Endometrial thickness during fresh IVF cycles helps to
predict endometrial development in future FET cycles.
This may help to identify patients who require additional
hormonal support for adequate endometrial development.
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